Hydra Biosciences' Partnership

Hydra Biosciences raised a round of funding on April 13, 2015. Investors include Boehringer Ingelheim.

Hydra Biosciences is a privately-held biopharmaceutical company based in Cambridge, Mass. that develops drugs to treat pain, inflammation, anxiety and other diseases using its expertise in novel ion c…

Articles about Hydra Biosciences' Partnership: